2 min read
Meet Veristat at the ASCO Annual Meeting
May 29 - June 2, 2026 | Chicago, IL
▶️ At the Forefront of Oncology Progress
Veristat is pleased to attend the ASCO...
Learn how our neuroscience team partner with sponsors across multiple therapeutic areas to accelerate trial success in complex neurological and psychiatric conditions. Our collaborative efforts have supported successful marketing applications, breakthrough therapy designations, and innovative trial solutions across rare and ultra-rare neurological disorders.
With 250+ clinical trials and projects completed in the past 10 years, we bring proven expertise to the most challenging neuroscience therapeutic areas. Our diverse trial experience includes drug, biologic, and diagnostic trials—including pediatric gene therapy, stroke cell therapy, and psychiatric NDA submissions, with more than 30% focused on rare or ultra-rare neurological diseases.
In our neurology/psychiatry portfolio, learn how our team has helped sponsors to solve challenges across numerous areas including:
Pediatric gene therapy advancement
Strategic NDA/BLA submission support
Complex stroke therapy logistics
Rare disease trial management
Regulatory approval navigation (FDA, EMA, and regional agencies)
International family coordination

2 min read
May 5, 2026 Veristat Events
May 29 - June 2, 2026 | Chicago, IL
Veristat is pleased to attend the ASCO...
1 min read
Apr 30, 2026 Veristat Events
May 12-13, 2026 – New Brunswick, NJ
Veristat is pleased to...